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Figure S1. Macrophages represent the main source of IL-12p40. (A) Aortic tissue obtained from 
WT mice on day 14-post elastase perfusion were stained for IL-12p40 (green) in MOMA-2+ 
(red, upper row) or CD8+ cells (red, lower row). Scale bar = 50 μm. L = Lumen. DAPI (blue) 
stained nuclei. (B) Percent of MOMA-2+IL-12p40+ vs CD8+IL-12p40+ cells were calculated 
from 3-4 nonoverlapping fields per aortic cross-section, 6-9 sections per aorta, n=6-8 aortas. 




Figure S2. Antagonism of IL-12p40 attenuates AAA development. Mice were perfused with 
elastase on day 0 and injected with anti-IL-12p40 or isotype control (250ug) on days 3 and 8. 
AD was assessed on day 14. AAA is expressed as the % increase in AD (A) or the change in 
AD in mm (B). Antagonism of IL-12p40 attenuated macrophage expansion (C) and the 
expression of IL12p40, IL-6, and TNF-a, and MMP9 (D-G). IL-12p40 antagonism also 
attenuated the expression of IL-17A (H). Values represent mean ± SEM, n = 7-8 mice per 




Figure S3. Antagonism of IL-23p19 attenuates AAA development. Mice were perfused with 
elastase on day 0 and injected with anti-IL-23p19 or isotype control (250ug) on days 3 and 8. 
AD was assessed on day 14. AAA is expressed as the % increase in AD (A) or the change in 
AD in mm (B). Antagonism of IL-23p19 attenuated macrophage expansion (C) and the 
expression of IL12p40, IL-6, TNF-a, and MMP9 and IL-17A expression (D-H). Values represent 























Figure S4. Antagonism of IL-12p40 and IL-23p19 suppresses T cell proliferation. Mice were 
perfused with elastase on day 0 and injected with anti-IL-12p40 or IL-23p19 or isotype control 
(250ug) on days 3 and 8. CD3+ T cells were enumerated on day 14. Values represent mean ± 
SEM, 6-9 sections per aorta, n=6-8 aortas. *p < 0.05, **p < 0.01, ***p < 0.001 
 
